AstraZeneca COVID-19 Vaccine Production Begins in Australia by CSL Limited: Report
The Sydney Morning Herald reported that it will take CSL about 50 days to completely process the vaccine. According to the newspaper, the company has separate contracts with AstraZeneca and the Australian government for the production of the vaccine.
Canberra, November 9: The CSL Limited company started production of the University of Oxford/AstraZeneca coronavirus vaccine on Monday, Australian media report. Thirty million doses of the vaccine will enter manufacturing in Victoria on Monday, according to Sydney's 2GB radio.
"[The vaccine] is going to be voluntary but we will encourage as many people as possible," Health Minister Greg Hunt told 2GB on Monday. "We are confident that we will have a very high take-up amongst the Australian population," he added. Also Read | Global COVID-19 Cases top 50 Million Mark, Death Toll Reaches 1,255,250, Says Johns Hopkins.
The Sydney Morning Herald reported that it will take CSL about 50 days to completely process the vaccine. According to the newspaper, the company has separate contracts with AstraZeneca and the Australian government for the production of the vaccine.
The AstraZeneca vaccine still needs to be approved by Australia's Therapeutic Goods Administration (TGA). Phase three clinical trials of the vaccine are expected to wrap up by the end of this year. According to Health Minister Greg Hunt, the vaccine will start to be available to the public in March.
(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)